Preserving confidentiality in the peer review process.
DeAngelis
Catherine D
CD
Thornton
Joseph P
JP
D000329:Advertising / Q000941:ethics / Q000331:legislation & jurisprudence*; D000068579:Celecoxib; D003219:Confidentiality; D052246:Cyclooxygenase 2 Inhibitors; D030881:Disclosure; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence*; D007555:Isoxazoles; D016365:Liability, Legal; D017712:Peer Review, Research / Q000941:ethics* / Q000331:legislation & jurisprudence*; D011720:Pyrazoles; D013449:Sulfonamides; D014481:United States; D000096926:Benzenesulfonamides
D000068579:Celecoxib; D052246:Cyclooxygenase 2 Inhibitors; D007555:Isoxazoles; D011720:Pyrazoles; D013449:Sulfonamides; C406224:valdecoxib; D000096926:Benzenesulfonamides